Abstract
It is established that in the main group trekrezan application in addition to basic chemotherapy, caused earlier (for 7-10 days) increase in concentration of LF — from 396.32±24.82 to 4069.32±114.06 ng/ml and F — from 26.2±1.8 ng/ml to 439.47±16.3 ng/ml, in comparison with group of control — 1335.41±39.71 ng/ml and 279.47±14.3 ng/ml, respectively. At the same time, classical clinical effectiveness indicators (concentration of total protein, urea, hemoglobin, erythrocytes, leukocytes and blood lymphocytes) were normalized in the main group of patients.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
